Zhejiang CONBA Pharmaceutical Co.,Ltd. announced that according to preliminary statistics of its financial department, the company predicts that the net profit belonging to shareholders of the listed company in 2017 will increase by between RMB 264.65 million and RMB 352.86 million with an increase of between 60% and 80% compared with the same period of the year before. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 200 million and RMB 290 million with an increase of between 41% and 60% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations).